- Home
- ALAR vs QNCX Comparison
ALAR vs QNCX Comparison
Compare ALAR & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- QNCX
- Stock Information
- Founded
- ALAR 2013
- QNCX 2012
- Country
- ALAR Israel
- QNCX United States
- Employees
- ALAR N/A
- QNCX N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALAR Technology
- QNCX Health Care
- Exchange
- ALAR Nasdaq
- QNCX Nasdaq
- Market Cap
- ALAR 45.3M
- QNCX 47.7M
- IPO Year
- ALAR 2018
- QNCX 2019
- Fundamental
- Price
- ALAR $11.05
- QNCX $1.31
- Analyst Decision
- ALAR Strong Buy
- QNCX Strong Buy
- Analyst Count
- ALAR 1
- QNCX 5
- Target Price
- ALAR $15.00
- QNCX $8.00
- AVG Volume (30 Days)
- ALAR 232.8K
- QNCX 302.6K
- Earning Date
- ALAR 05-29-2025
- QNCX 08-12-2025
- Dividend Yield
- ALAR N/A
- QNCX N/A
- EPS Growth
- ALAR N/A
- QNCX N/A
- EPS
- ALAR 0.07
- QNCX N/A
- Revenue
- ALAR $30,581,000.00
- QNCX N/A
- Revenue This Year
- ALAR N/A
- QNCX N/A
- Revenue Next Year
- ALAR $12.28
- QNCX N/A
- P/E Ratio
- ALAR $16.75
- QNCX N/A
- Revenue Growth
- ALAR 4.67
- QNCX N/A
- 52 Week Low
- ALAR $5.45
- QNCX $0.51
- 52 Week High
- ALAR $46.69
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- ALAR 65.81
- QNCX 64.64
- Support Level
- ALAR $10.43
- QNCX $1.29
- Resistance Level
- ALAR $12.25
- QNCX $1.45
- Average True Range (ATR)
- ALAR 0.83
- QNCX 0.09
- MACD
- ALAR 0.21
- QNCX 0.03
- Stochastic Oscillator
- ALAR 73.26
- QNCX 76.74
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.